The startup has developed a non-invasive device that utilizes artificial intelligence to measure blood glucose levels from interstitial fluid without skin penetration. This technology provides users with real-time glucose trend data, eliminating the need for expensive consumables typically associated with traditional glucose monitoring methods.
Funding
$540K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional blood glucose monitoring methods require invasive skin penetration, causing discomfort and inconvenience for users. These methods also rely on expensive consumables, adding to the ongoing cost of diabetes management.
Solution
This startup is developing a non-invasive device that uses artificial intelligence to measure blood glucose levels from interstitial fluid without puncturing the skin. The device provides real-time glucose trend data, enabling users to monitor their glucose levels continuously and make informed decisions about their health. By eliminating the need for lancets and test strips, the technology offers a more convenient and cost-effective solution for glucose monitoring. The device aims to improve the user experience and reduce the burden associated with traditional diabetes management.
Target Audience
The primary target audience includes individuals with diabetes who require regular glucose monitoring, as well as healthcare providers seeking more convenient and cost-effective solutions for their patients.
Features
- Non-invasive glucose measurement using interstitial fluid analysis
- Real-time glucose trend data display
- AI-powered algorithms for accurate glucose level prediction
- Wireless data transmission to a mobile app or cloud platform
- Integration with existing diabetes management platforms
- User-friendly interface for easy data interpretation